U.S., Sept. 6 -- ClinicalTrials.gov registry received information related to the study (NCT07158151) titled 'A Phase II Trial of the Safety and Efficacy of RSS0309 Ointment in Adults With Atopic Dermatitis' on Aug. 28.
Brief Summary: This study is ongoing to explore the efficacy and safety of different strengths of RSS0393 ointment in adults with atopic dermatitis
Study Start Date: Sept., 2025
Study Type: INTERVENTIONAL
Condition:
Atopic Dermatitis of Adults
Intervention:
DRUG: RSS0393 ointment
RSS0393 ointment 0.05%
DRUG: RSS0393 ointment
RSS0393 ointment 0.01%
DRUG: RSS0393 ointment
RSS0393 ointment 0.03%
DRUG: RSS0393 ointment
RSS0393 ointment placebo
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Reistone Biopharma Comp...